Advertisement

Techniques in Coloproctology

, Volume 21, Issue 9, pp 767–769 | Cite as

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: from novelty to routine in selected cases

Cochrane Digest

Notes

Compliance with ethical standards

Conflict of interest

The author has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Verzijden J, Klaver Y, de Hingh IHJT, Bleichrodt RP (2017) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis in patients with colorectal cancer. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD008479. Last updated 23 August 2017
  2. 2.
    Verzijden J, Klaver Y, de Hingh IHJT, Bleichrodt R (2010) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis in patients with colorectal cancer. Cochrane Rev. doi: 10.1002/14651858.CD008479
  3. 3.
    Moran BJ, Cecil TD (2014) Treatment of surgically resectable colorectal peritoneal metastases. Br J Surg 101:5–7CrossRefPubMedGoogle Scholar
  4. 4.
    Verwaal VJ, Van Ruth S, de Bree E, van Sloothen GW et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinmatosis of colorectal cancer. J Clin Oncol 21:3737–3743CrossRefPubMedGoogle Scholar

Copyright information

© Crown Copyright  2017

Authors and Affiliations

  1. 1.Peritoneal Malignancy Institute BasingstokeHampshire Hospitals Foundation TrustBasingstokeUK

Personalised recommendations